A two-part webinar series featuring
Epstein Becker Green, Yale Behavioral Health, and Edgemont Capital

Watch the Video on Youtube or Here:

Part I - Substance Abuse Disorder Providers
Tuesday, June 12, 2018
2:00 – 3:00 p.m. ET
Webinar

Part II - Autism Condition Providers
Thursday, July 12, 2018
2:00 – 3:00 p.m. ET
Webinar

Private-equity firms and national health care companies are focused on acquisitions of, and investments in, health care companies involved in the treatment of substance use disorders and autism spectrum conditions. More people than ever require treatment from facilities and other health care providers focused on these conditions, and there have been record levels of federal and state funding for these patients—all of which have positively impacted the market valuation of these companies. Moving forward, we expect to see increasing activity in the addiction and autism service spaces as markets mature and investors partner with clinical providers to deliver these essential services to growing populations.

Before committing substantial capital to acquisitions, potential buyers and investors conduct robust due diligence to confirm that target companies are operating in a legal and compliant manner. These webinars, through a unique multidisciplinary team format, will describe vital components of the due diligence process, identifying the key clinical, quality-of-care, regulatory, and operational factors that will be under scrutiny in assessing a company’s value and the sustainability of its revenues.

Webinar panelists include:

  • A national health care investment banker focusing on this space who will discuss:
    • Recent market activity and trends in the substance abuse and autism sectors, as well as important considerations in assessing the value of companies in these sectors
    • What is involved in competitive processes seeking investment, partnership, and/or sale
  • The chief operating officer of Yale Behavioral Health, with extensive experience in clinical due diligence and operational assessments in the behavioral health industry, along with a healthcare regulatory attorney with similar experience, who will discuss:
    • Major clinical and compliance issues that arise in the industry that can have a negative effect on the revenue of substance abuse and autism treatment providers
    • Strategies for best positioning your company to be compliant and avoid devaluation in the transaction process
  • A national health care mergers and acquisitions attorney who will discuss:
    • How to get your corporate house in order before venturing into a potential competitive process or transaction
    • Key deal issues to address when negotiating contract terms for a strategic investment and/or sale transaction

Moderator:

Gary W. Herschman
Member of the Firm 
Epstein Becker Green
gherschman@ebglaw.com

Panelists:

Paul D. Gilbert
Member of the Firm
Epstein Becker Green
pgilbert@ebglaw.com

Erik Kistler
Vice President
Edgemont Capital
erik@edgemontcapital.com

Kevin J. Malone
Associate
Epstein Becker Green
kmalone@ebglaw.com

Scott Migdole
Assistant Clinical Professor (Social Work) of Psychiatry,
Yale School of Medicine;
Chief Operating Officer,
Yale Behavioral Health
scott.migdole@yale.edu

Megan Robertson
Associate
Epstein Becker Green
mrobertson@ebglaw.com

If you have questions regarding this event, please contact Whitney Krebs.

Event Detail

Webinar (ET)
Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.